Literature DB >> 16328959

Iron-loaded cardiac myocytes stimulate cardiac myofibroblast DNA synthesis.

Ying Liu1, Douglas M Templeton.   

Abstract

Cardiac fibrosis in iron overload disorders may arise from activation of the interstitial fibroblast. However, the cardiac myocyte, and not the fibroblast, is the main target for iron deposition. We hypothesized that fibroblasts respond to the presence of iron-loaded myocytes with increased proliferative capacity. Cardiac fibroblasts were either co-cultured with myocytes on porous filters or treated with medium conditioned by growth of myocyte cultures. In both circumstances myocytes suppressed [(3)H]thymidine incorporation by fibroblasts over 24 h, compared to stimulation of quiescent fibroblasts with fresh, unconditioned medium. However, when the myocytes were preloaded with iron, the suppressive effect was lost and DNA synthesis was restored to levels seen in unconditioned medium. This effect was not due to early events in cell cycle entry; activation of Erk at 15 min and expression of c-fos mRNA at 30 min were similar in media from control and iron-loaded myocytes. Early markers of progression of G1, namely cyclin D and phosphoretinoblastoma protein, were not significantly different in fibroblasts treated with either conditioned medium. However, cyclin E expression, a marker of the G1/S transition, was significantly increased by conditioned medium from the iron-loaded cells, compared to control-conditioned medium. We conclude that myocytes can suppress proliferation of fibroblasts by cumulative effects on late G1 events leading to DNA synthesis, and these effects are diminished with myocyte iron accumulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16328959     DOI: 10.1007/s11010-006-0388-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

1.  Hemochromatosis: the irony of population screening.

Authors:  P C Adams
Journal:  Scand J Gastroenterol       Date:  2001-10       Impact factor: 2.423

Review 2.  Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.

Authors:  Alexis Desmoulière; Ian A Darby; Giulio Gabbiani
Journal:  Lab Invest       Date:  2003-12       Impact factor: 5.662

Review 3.  The biology of the myofibroblast.

Authors:  G Gabbiani
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

4.  Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo.

Authors:  P E McEwan; G A Gray; L Sherry; D J Webb; C J Kenyon
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

5.  Transforming growth factor-beta, other growth factors, and the extracellular matrix.

Authors:  M A Haralson
Journal:  J Lab Clin Med       Date:  1997-11

6.  Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution.

Authors:  A C Nag
Journal:  Cytobios       Date:  1980

Review 7.  Fibrogenesis. V. TGF-beta signaling pathways.

Authors:  R G Wells
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

8.  Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study.

Authors:  T Lombardo; C Tamburino; G Bartoloni; M L Morrone; V Frontini; F Italia; S Cordaro; A Privitera; V Calvi
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

9.  Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan.

Authors:  Ching-Tien Peng; Kuan-Chih Chow; Jeon-Hor Chen; Yi-Ping Chiang; Tze-Yi Lin; Chang-Hai Tsai
Journal:  Eur J Haematol       Date:  2003-06       Impact factor: 2.997

10.  The effects of cardiac myocytes on interstitial fibroblasts in toxic iron overload.

Authors:  Y Liu; D M Templeton
Journal:  Cardiovasc Toxicol       Date:  2001       Impact factor: 3.231

View more
  6 in total

1.  Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis.

Authors:  Chaoqun Huang; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Xuxu Gou; Roshini Sathiaseelan; Lakmini Kumari Senavirathna; Pengcheng Wang; Lin Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

2.  Cardioprotection by Hepc1 in cTnT(R141W) transgenic mice.

Authors:  Li Zhang; Dan Lu; Wei Zhang; Xiongzhi Quan; Wei Dong; Yanfeng Xu; Lianfeng Zhang
Journal:  Transgenic Res       Date:  2011-12-24       Impact factor: 2.788

3.  Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.

Authors:  Collynn F Woeller; Charles W O'Loughlin; Stephen J Pollock; Thomas H Thatcher; Steven E Feldon; Richard P Phipps
Journal:  FASEB J       Date:  2014-11-21       Impact factor: 5.191

4.  Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  Paul Kirk; John Paul Carpenter; Mark A Tanner; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-17       Impact factor: 5.364

5.  Effects of basic fibroblast growth factor and cyclin D1 on cigarette smoke-induced pulmonary vascular remodeling in rats.

Authors:  Sijing Zhou; Min Li; Daxiong Zeng; Gengyun Sun; Junsheng Zhou; Ran Wang
Journal:  Exp Ther Med       Date:  2014-10-31       Impact factor: 2.447

6.  Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia.

Authors:  Paul Kirk; Mary Sheppard; John-Paul Carpenter; Lisa Anderson; Taigang He; Tim St Pierre; Renzo Galanello; Gualtiero Catani; John Wood; Suthat Fucharoen; John B Porter; J Malcolm Walker; Gian Luca Forni; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2017-03-27       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.